Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TVTX
#1492
Travere Therapeutics, Inc. Common Stock
29.790
0
+3.83%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+3.83%
Monthly Change
-0.37%
6 month change
+3.55%
Year Change
+3.55%
Previous Close
28.690
0
Open
29.790
0
Bid
Ask
Low
29.790
0
High
29.790
0
Volume
138
Markets
US Stock Market
Healthcare
TVTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
60.24 M
63.21 M
64.74 M
76.1 M
88.74 M
92.24 M
—
Valuation ratios
Enterprise value
1.56 B
1.8 B
1.28 B
669.33 M
1.49 B
3.43 B
8.23 B
Price to earnings ratio
—
-10.31
-4.73
-6.37
-4.27
-131.76
-168.49
Price to sales ratio
—
8.16
6.21
4.89
5.89
6.95
20.97
Price to cash flow ratio
—
125.55
7.07
2.54
5.79
90.22
142.12
Price to book ratio
—
6.15
30.74
3.54
23.26
29.69
58.86
Enterprise value to EBITDA ratio
-21.23
-13.03
-60.29
-1.73
-5.76
-55.99
-84.91
Profitability ratios
Return on assets %
0.28
0.23
0.41
0.14
0.54
0.04
0.06
Return on equity %
0.8
0.6
6.5
0.55
5.44
0.22
1.52
Return on invested capital %
266.12
269.48
449.73
578.2
346.46
76.72
53.95
Gross margin %
96.91
97.02
96.42
92.12
96.68
97.89
390.02
Operating margin %
88.83
71.11
125.73
267.24
138.88
12.8
64.95
EBITDA margin %
-36.98
-60.59
-9.98
-265.69
-110.65
-12.49
-103.82
Net margin %
85.43
79.16
131.35
76.7
137.9
5.21
35.43
Liquidity ratios
Quick ratio
4.35
4.64
3.37
3.41
2.04
2.51
8.63
Current ratio
4.43
4.7
3.42
3.47
2.08
2.74
9.54
Inventory turnover
0.89
0.91
1.07
1.4
0.99
0.49
0.36
Asset turnover
0.33
0.33
0.29
0.2
0.34
0.82
0.88
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.35
0.29
0.56
0.48
0.52
0.52
2.22
Long term debt to total equity ratio
1.02
0.75
8.76
1.88
5.25
2.71
25.91
Per share metrics
Operating cash flow per share
—
0.25
2.92
3.77
3.01
0.42
0.43
EBIT per share
—
-2.75
-0.85
-5.71
-3.82
-1.37
-1.84
EBITDA per share
—
-2.3
-0.33
-5.2
-3.27
-0.69
-1.16
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
7.15
5.45
4.13
0.74
2.67
7.03
Net current asset value per share
—
9.74
7.63
8.3
5.28
4.9
17.58
Tangible book value per share
—
2.55
-1.62
1.29
-0.58
0.01
-2.04
Working capital per share
—
7.67
5.4
5.91
2.74
3.11
10.08
Book value per share
—
5.05
0.67
2.7
0.75
1.29
2.85
News
Travere Therapeutics: FILSPARI Drives Revenue, FSGS PDUFA Looms (NASDAQ:TVTX)
Travere Therapeutics, Inc. (TVTX) Q4 2025 Earnings Call Transcript
Travere Therapeutics (TVTX) Matches Q4 Earnings Estimates
Travere Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:TVTX) 2026-02-19
Travere Therapeutics posts surprise Q4 profit; Shares slip 5% on revenue miss
Travere Therapeutics earnings beat by $0.41, revenue fell short of estimates
Walmart, Southern Co, Newmont Mining and more set to report earnings Thursday
Kiniksa Pharmaceuticals International, plc (KNSA) Earnings Expected to Grow: Should You Buy?
Travere Therapeutics (TVTX) Earnings Expected to Grow: Should You Buy?
Travere Therapeutics at Guggenheim Summit: Confident in Strategic Path
Nurix Therapeutics, Inc. (NRIX) Reports Q4 Loss, Misses Revenue Estimates
Travere therapeutics CEO Dube sells $1.8 million in TVTX stock